Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00945841 | Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010 | PHASE3 | COMPLETED | 126 | — | — | Jun 1, 2009 | Jun 1, 2009 | Apr 7, 2017 | 3 | Germany |
| Arm | Type | Description |
|---|---|---|
| 1 | OTHER | - |
| Name | Type | Description |
|---|---|---|
| inactivated split influenza vaccine | BIOLOGICAL | 1 dose of inactivated split influenza vaccine, using the strain composition 2009/2010 |
Inclusion Criteria: Subjects eligible for enrollment into this study are male and female adults who are 1. ≥ 18 years of age, mentally competent, willing and able to give informed consent prior to study entry 2. Able to comply with all study requirements 3. In good health as determined by: * M...